
Biophytis Completes €2.6 Million Private Placement

I'm PortAI, I can summarize articles.
Biophytis SA has successfully completed a private placement worth approximately €2.6 million, involving the issuance of new ordinary shares and pre-funded warrants now trading on Euronext Growth. This financial move, facilitated by Maxim Group LLC and Invest Securities, aims to strengthen Biophytis's financial position and support its operations in developing treatments for age-related diseases. The company is currently listed on Euronext Growth Paris with a market cap of €3.18 million and has experienced a year-to-date price performance decline of 43.43%.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

